← Back to Search

Diet & Exercise Counseling for Weight Loss in Survivors of Childhood Leukemia

Q: Is enrollment in this research study still available to participants?

<p>According to the details reported on clinicaltrials.gov, this specific medical study is no longer recruiting participants. Initially posted in September 2014 and last updated in July 2022, it has been superseded by 1411 other trials actively seeking volunteers at present.</p>

N/A

Waitlist Available

Led By Emily Tonorezos, MD, MPH

Research Sponsored by Memorial Sloan Kettering Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Diagnosed with acute lymphoblastic leukemia < 18 years of age

Cancer free at time of study enrollment

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 24 months

Awards & highlights

Study Summary

This trial will compare two ways of helping people who are overweight or obese lose weight.

Who is the study for?

The EQUAL study is for adult survivors of childhood acute lymphoblastic leukemia (ALL) who are now overweight or obese. Participants must be at least 18 years old, have a BMI of 25 or higher, internet access with an email account, and be cancer-free at enrollment. They can't join if they've had total body irradiation, conditions where weight loss isn't advised, used weight loss meds recently, or have certain heart diseases.Check my eligibility

What is being tested?

This study tests whether diet and exercise guidance helps adult survivors of childhood ALL lose weight and improve health. Over two years, it compares personalized counseling with website support against self-directed weight loss efforts using questionnaires and health measurements.See study design

What are the potential side effects?

There may not be direct side effects from the interventions since they involve lifestyle changes like dieting and exercising. However, participants might experience general discomforts such as muscle soreness from new physical activities or hunger from dietary restrictions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I was diagnosed with leukemia before turning 18.

Select...

I am currently free of cancer.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 24 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~24 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Weight loss

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Intervention groupExperimental Treatment3 Interventions

Participants will be assigned an individual diet & physical activity counselor through Healthways at Hopkins. This counselor will stay with the participant for the 24 months. The primary communication with the counselor will be via website & email. Participants will be encouraged to consume a low-calorie, low-salt diet with 7-12 daily servings of fruits, vegetables & low-fat dairy products. Calorie goals are based upon weight at study entry & whether or not the weight loss goal has been met. Participants will gradually build to ≥ 180 minutes of moderate to vigorous physical activity per week, using the activity of their own choosing & gradually adding bouts of ≥ 10 minutes in length. Monitoring & Counselor Contacts: the first 3 months, the participants are encouraged to log into the web hub on a daily basis to record weight, food intake, & physical activity. Participants who decline or drop out of the intervention program will remain on-study doing home visits & questionnaires.

Group II: control groupActive Control3 Interventions

Participants will receive general information brochures on healthy living and weight loss but will not have access to the Healthways at Hopkins website or counselors.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

questionnaires

2008

Completed Phase 2

~3450

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor

1,933 Previous Clinical Trials

585,264 Total Patients Enrolled

Johns Hopkins UniversityOTHER

2,259 Previous Clinical Trials

14,820,295 Total Patients Enrolled

St. Jude Children's Research HospitalOTHER

427 Previous Clinical Trials

5,306,219 Total Patients Enrolled

Media Library

self directed weight loss Clinical Trial Eligibility Overview. Trial Name: NCT02244411 — N/A

Survivors of Childhood Leukemia Research Study Groups: Intervention group, control group

Survivors of Childhood Leukemia Clinical Trial 2023: self directed weight loss Highlights & Side Effects. Trial Name: NCT02244411 — N/A

self directed weight loss 2023 Treatment Timeline for Medical Study. Trial Name: NCT02244411 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment in this research study still available to participants?

"According to the details reported on clinicaltrials.gov, this specific medical study is no longer recruiting participants. Initially posted in September 2014 and last updated in July 2022, it has been superseded by 1411 other trials actively seeking volunteers at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Exercise and QUality Diet After Leukemia: The EQUAL Study

2014. "Exercise and QUality Diet After Leukemia: The EQUAL Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02244411.